Cambridge Investment Research Advisors’s T. Rowe Price Capital Appreciation Premium Income ETF TCAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
76,914
+2,360
+3% +$52.8K ﹤0.01% 1817
2026
Q1
$1.67M Buy
74,554
+3,268
+5% +$76.7K ﹤0.01% 1740
2025
Q4
$1.68M Buy
71,286
+34,385
+93% +$827K ﹤0.01% 1688
2025
Q3
$900K Buy
36,901
+26,236
+246% +$646K ﹤0.01% 2131
2025
Q2
$263K Buy
+10,665
New +$263K ﹤0.01% 3091

Other funds holding TCAL

Cambridge Investment Research Advisors's TCAL Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its T. Rowe Price Capital Appreciation Premium Income ETF (TCAL) stake by 3.2% in Q2 2026, buying an estimated $52.8K and bringing the position to 76,914 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Cambridge Investment Research Advisors first reported a position in TCAL in Q2 2025 and has held it in 5 quarters since. 70 funds tracked by Wall St. Rank hold TCAL as of Q2 2026.

  • Cambridge Investment Research Advisors held 76,914 shares of T. Rowe Price Capital Appreciation Premium Income ETF worth $1.71M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 2,360 T. Rowe Price Capital Appreciation Premium Income ETF shares in Q2 2026, an estimated $52.8K.
  • T. Rowe Price Capital Appreciation Premium Income ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1817 holding.
  • Cambridge Investment Research Advisors first reported a position in T. Rowe Price Capital Appreciation Premium Income ETF in Q2 2025 and has held it in 5 quarters since.
  • 70 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Premium Income ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.